Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CNJ Capital Investments Inc T.CNJ


Primary Symbol: V.CNJ.P

CNJ Capital Investments Inc. is a Canada-based capital pool company (CPC). The Company’s business is to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The Company has not conducted commercial operations. The Company has not generated any revenues.


TSXV:CNJ.P - Post by User

Bullboard Posts
Comment by SurfForWealthon Jan 30, 2006 5:56pm
108 Views
Post# 10269428

Positive News

Positive NewsMCristo, this might make you feel a little better. I believe this to be very positive for the company. Sure took a long time for this approval. I have been out for a long time. Might have to catch up on the story. U.S. FDA approves Cangene's anti-hepatitis B product Monday January 30, 5:05 pm ET Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, Jan. 30 /CNW/ - Cangene today announces that the U.S. Food and Drug Administration (FDA) has approved Cangene's HepaGam B(TM) for treatment following acute exposure to hepatitis B virus. HepaGam B(TM) is Cangene's hepatitis B immune globulin (human), a purified antibody or hyperimmune that is specific for the hepatitis B virus. Hepatitis B is a highly infectious virus that can be spread through contact with blood and other bodily fluids from an infected person or can be transmitted from an infected mother to a newborn during birth. more..... https://biz.yahoo.com/cnw/060130/cangene_hepb_approval.html?.v=1
Bullboard Posts